Cleared Traditional

K833037 - POINTER F-3

K833037 is an FDA 510(k) clearance for POINTER F-3, manufactured by Petra Intl. Co.. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 83-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1983
Decision
83d
Days
Class 2
Risk

K833037 is an FDA 510(k) clearance for the POINTER F-3. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Petra Intl. Co. (Mchenry, US). The FDA issued a Cleared decision on November 29, 1983 after a review of 83 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K833037

510(k) Number K833037 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 07, 1983
Decision Date November 29, 1983
Days to Decision 83 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
66d faster than avg
Panel avg: 149d · This submission: 83d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 605
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K833037.
NEUROTRON 100
K833086 · Neutro-Tronics · Jan 1984
MINI-1 TRANSCUTANEOUS ELEC-NERVE STIM
K834215 · Th Charters, Inc. · Jan 1984
TRANSCUTANEOUS ELECTRONIC NERVE STIMU
K831938 · Joseph M. Piocentile · Dec 1983
NEUROFLAX, EPK
K831990 · Franks Electronics · Nov 1983
AUTO-TENS MODEL VI DUAL CHANNEL BATT
K833354 · Physio Tronics Corp. · Nov 1983
ELECTRO-PULSE
K832160 · Electro-Pulse · Nov 1983